Recent advances in CRISPR-Cas9-based genome insertion technologies by Xinwen Chen, Jingjing Du, Shaowei Yun, Chaoyou Xue, Yao Yao, Shuquan Rao

Connect to this object online.

Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study by Wenxin Hong, Yan Chen, Yan Chen, Kai You, Kai You, Shenglin Tan, Shenglin Tan, Feima Wu, Jiawang Tao, Jiawang Tao, Xudan Chen, Jiaye Zhang, Jiaye Zhang, Yue Xiong, Yue Xiong, Fang Yuan, Fang Yuan, Zhen Yang, Zhen Yang, Tingting Chen, Xinwen Chen, Xinwen Chen, Ping Peng, Qiang Tai, Jian Wang, Fuchun Zhang, Yin-Xiong Li, Yin-Xiong Li, Yin-Xiong Li, Yin-Xiong Li

Connect to this object online.

Human induced-T-to-natural killer cells have potent anti-tumour activities by Zhiwu Jiang, Le Qin, Yuou Tang, Rui Liao, Jingxuan Shi, Bingjia He, Shanglin Li, Diwei Zheng, Yuanbin Cui, Qiting Wu, Youguo Long, Yao Yao, Zhihui Wei, Qilan Hong, Yi Wu, Yuanbang Mai, Shixue Gou, Xiaoping Li, Robert Weinkove, Sam Norton, Wei Luo, Weineng Feng, Hongsheng Zhou, Qifa Liu, Jiekai Chen, Liangxue Lai, Xinwen Chen, Duanqing Pei, Thomas Graf, Xingguo Liu, Yangqiu Li, Pentao Liu, Zhenfeng Zhang, Peng Li

Connect to this object online.